Economic evaluation of plerixafor for stem cell mobilization

NHS Economic Evaluation Database - NHS EED
Publication date:
08 May 2013


Bibliographic details

Kymes SM, Pusic I, Lambert DL, Gregory M, Carson KR, DiPersio JF.  Economic evaluation of plerixafor for stem cell mobilization. American Journal of Managed Care 2012; 18(1): 33-41


This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.

CRD summary

Indexing status

Subject indexing assigned by NLM

Index terms

Costs and Cost Analysis; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds /administration & dosage /economics /therapeutic use; Humans; Lymphoma, Non-Hodgkin /drug therapy; Markov Chains; Outcome Assessment (Health Care)